Literature DB >> 10447648

REP-1 gene mutations in Japanese patients with choroideremia.

K Fujiki1, Y Hotta, M Hayakawa, A Saito, Y Mashima, M Mori, M Yoshii, A Murakami, M Matsumoto, S Hayasaka, N Tagami, Y Isashiki, N Ohba, A Kanai.   

Abstract

BACKGROUND: Choroideremia (CHM) is an X-linked progressive dystrophy of the choroid, retinal pigment epithelium, and retina. Recently, the REP-1 gene was isolated and the causative mutations in the gene were detected in patients with CHM. In a previous study, we described a Japanese family with CHM who had a mutation in the REP-1 gene. In the present study, we performed extensive analysis of the REP-1 gene in patients with CHM from several institutions in Japan.
METHODS: Twenty-six patients with CHM and 5 unaffected females from 22 independently ascertained families were examined. Exons 1-15 of the REP-1 gene were screened by single-strand conformation polymorphism. The DNA fragments suspected of any variations were directly sequenced.
RESULTS: Fifteen different mutations, including one previously reported mutation, were detected in 18 families. In addition, carrier status was proven in four unaffected females found to be heterozygous for the mutant allele.
CONCLUSIONS: Fifteen different mutations of the REP-1 gene were detected in 18 Japanese families. There were no hot spots for the mutations and no missense mutations. The results show that REP-1 gene defects cause CHM in Japanese patients, and the mutations in these Japanese patients differed from the mutations reported for CHM patients in Europe, Canada, and America except for R267X and 1313delTC. These findings suggest that the mutations occurred independently in the Japanese patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447648     DOI: 10.1007/s004170050305

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Ilaria Passerini; Simona Palchetti; Andrea Sodi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-27       Impact factor: 3.117

2.  Novel types of mutation in the choroideremia ( CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon.

Authors:  José A J M van den Hurk; Dorien J R van de Pol; Bernd Wissinger; Marc A van Driel; Lies H Hoefsloot; Ilse J de Wijs; L Ingeborgh van den Born; John R Heckenlively; Han G Brunner; Eberhart Zrenner; Hans-Hilger Ropers; Frans P M Cremers
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

3.  A novel mutation (967-970+2)delAAAGGT in the choroideremia gene found in a Japanese family and related clinical findings.

Authors:  Yutaka Iino; Takuro Fujimaki; Keiko Fujiki; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

4.  Genetic and phenotypic characteristics of three Mainland Chinese families with choroideremia.

Authors:  Qi Zhou; Liang Liu; Fei Xu; Hui Li; Yuri Sergeev; Fangtian Dong; Ruxin Jiang; Ian MacDonald; Ruifang Sui
Journal:  Mol Vis       Date:  2012-02-03       Impact factor: 2.367

5.  Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy.

Authors:  Paul R Freund; Yuri V Sergeev; Ian M MacDonald
Journal:  Mol Genet Genomic Med       Date:  2016-02-28       Impact factor: 2.183

6.  Next-generation sequencing-based molecular diagnosis of 35 Hispanic retinitis pigmentosa probands.

Authors:  Qi Zhang; Mingchu Xu; Jennifer D Verriotto; Yumei Li; Hui Wang; Lin Gan; Byron L Lam; Rui Chen
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

7.  microRNAs and genetic diseases.

Authors:  Nicola Meola; Vincenzo Alessandro Gennarino; Sandro Banfi
Journal:  Pathogenetics       Date:  2009-11-04

8.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

9.  Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia.

Authors:  Kayo Shimizu; Akio Oishi; Maho Oishi; Ken Ogino; Satoshi Morooka; Masako Sugahara; Norimoto Gotoh; Nagahisa Yoshimura
Journal:  Case Rep Ophthalmol       Date:  2015-07-25

Review 10.  Recent advances and future prospects in choroideremia.

Authors:  Martin S Zinkernagel; Robert E MacLaren
Journal:  Clin Ophthalmol       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.